Michal B.
- Country
- Czechia
- Department
- Neurology
Research Overview
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia
- A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures
- Efficacy and Safety Evaluation of Botulinum Toxin Type A in Chronic Migraine Prevention in Adults: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 334 of 932 partner sites.
Specializations
Neurodegenerative Disorders
Specializes in investigating therapeutic approaches for Alzheimer's Disease, with particular focus on treatments for mild cognitive impairment and early-stage dementia. The investigator studies innovative interventions targeting cognitive decline and disease progression.
- Mild Cognitive Impairment
- Early-stage Alzheimer's Disease
- Cognitive Function Assessment
Neurological Disorders
Conducts research in the treatment of epilepsy and seizure disorders, including both acute interventions and long-term management strategies. Also investigates various types of migraine headaches, including both chronic and episodic presentations.
- Focal Seizures
- Chronic Migraine
- Episodic Migraine
Cardiovascular Conditions
Focuses on stroke prevention and treatment, particularly in patients with atrial fibrillation. Investigates advanced therapeutic approaches for ischemic stroke and various cardiovascular complications.
- Atrial Fibrillation Management
- Stroke Prevention
- Cardioembolic Events
- Transient Ischemic Attack
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.